This study will investigate whether a drug called Ambroxol can improve the course of Parkinson’s Dementia.
Participants should be:
- Over 50
- Have a diagnosis of Parkinson’s with cognitive impairment (e.g., forgetfulness)
- Have a Caregiver
- Be able to perform memory, movement (e.g., walking) and laboratory tests (e.g., blood draw)
For more information, please contact Carolina Silveira, Clinical Trial Coordinator 519-646-6100 ext. 42367